Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates
Clinical and Experimental Pediatrics · 15.01.2024 · 67 (1) · 26-34
DOI: 10.3345/cep.2021.01466 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.01.2024. Verfasst von Tae Hoon Eom und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders found in children and adolescents. The American Academy of Pediatrics (AAP) first published a clinical practice guideline on ADHD in 2000, which was revised in 2011 and republished together with an accompanying process-of-care algorithm. More recently, the 2019 clinical practice guideline revision was published. Since the 2011 guideline, the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), was released. In addition, the Society of Developmental and Behavioral Pediatrics (SDBP) recently released another clinical practice guideline for complex ADHD. Although there are nonessential changes reflected in these updates, a number of changes have still been made; for example, the DSM-5 criteria lowered the diagnostic threshold for ADHD in older teens and adults. Additionally, the criteria were revised to facilitate application to older teens and adults, and a comorbid diagnosis with autism spectrum disorder is now allowed. Meanwhile, the 2019 AAP guideline added the recommendation related to comorbid conditions with ADHD. Lastly, SDBP developed a complex ADHD guideline, covering areas such as comorbid conditions, moderate-to-severe impairment, treatment failure, and diagnostic uncertainty. In addition, other national ADHD guidelines have been published, as have European guidelines for managing ADHD during the coronavirus disease 2019 pandemic. To facilitate ADHD management in a primary care, it is important to provide and review clinical guidelines and recent updates. In this article, we will review and summarize the recent clinical guidelines and their updates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Pediatrics, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Zitieren
APA
Eom, T. H., & Kim, Y. H. (2024). Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates. Clinical and Experimental Pediatrics, 67(1), 26-34. https://doi.org/10.3345/cep.2021.01466
Vancouver
Eom TH, Kim YH. Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates. Clinical and Experimental Pediatrics. 2024;67(1):26-34. doi:10.3345/cep.2021.01466
BibTeX
@article{Eom2024,
author = {Eom, Tae Hoon and Kim, Young-Hoon},
title = {Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates},
journal = {Clinical and Experimental Pediatrics},
year = {2024},
volume = {67},
number = {1},
pages = {26--34},
doi = {10.3345/cep.2021.01466}
}
EUVIMED